Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Laparoscopic surgery to improve immune function in cirrhosis patients

Official title: The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Run by Northern Jiangsu People's Hospital · NCT05338294 · Data updated 2026-11-12

This study is testing if a specific type of surgery can help boost the immune system in people with liver cirrhosis who have an enlarged spleen.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorNorthern Jiangsu People's Hospital
Academic / other
Locations1 site (Yangzhou, Jiangsu)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedJuly 31, 2025
Study endsJuly 31, 2025
Registry record updatedMay 28, 2025
Trial IDNCT05338294 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with cirrhosis, splenomegaly, and gastroesophageal variceal bleeding who can provide informed consent.

Probably not a fit

Patients with hepatocellular carcinoma, severe liver dysfunction (Child-Pugh grade C), or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of laparoscopic splenectomy and azygoportal disconnection on immune function in patients with liver cirrhosis. Patients diagnosed with cirrhosis and experiencing splenomegaly will undergo the surgical procedure, followed by a standardized treatment plan and monitoring of immune-related indicators at various intervals post-surgery. The goal is to determine if this surgical intervention can enhance immune function and improve overall patient prognosis.

Why it matters

Potential benefit: If successful, this approach could significantly enhance immune function in cirrhosis patients, potentially leading to better health outcomes.

How similar studies have gone: While similar surgical approaches have been explored, this specific combination of procedures and its impact on immune function in cirrhosis patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
* Splenomegaly with secondary hypersplenism
* gastroesophageal variceal bleeding
* Informed consent to participate in the study

Exclusion Criteria:

* Hepatocellular carcinoma or any other malignancy,
* Child-Pugh grade C
* Recent peptic ulcer disease
* History of Hemorrhagic stroke
* Pregnancy.
* Uncontrolled Hypertension
* Human immunodeficiency virus (HIV) infection

Where it's running

  • Clinical Medical College, Yangzhou University
    Yangzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.